Production (Stage)
Medpace Holdings, Inc.
MEDP
$447.49
-$8.19-1.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.01% | 4.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.01% | 4.10% | |||
| Cost of Revenue | 4.50% | 6.14% | |||
| Gross Profit | 9.65% | 3.17% | |||
| SG&A Expenses | -19.40% | 27.43% | |||
| Depreciation & Amortization | 1.21% | -7.67% | |||
| Other Operating Expenses | 17.33% | 6.11% | |||
| Total Operating Expenses | 7.17% | 8.23% | |||
| Operating Income | 11.29% | -9.46% | |||
| Income Before Tax | 5.39% | -11.74% | |||
| Income Tax Expenses | 858.83% | -78.80% | |||
| Earnings from Continuing Operations | -21.24% | -2.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.24% | -2.07% | |||
| EBIT | 11.29% | -9.46% | |||
| EBITDA | 10.71% | -9.35% | |||
| EPS Basic | -16.32% | -0.27% | |||
| Normalized Basic EPS | 11.97% | -10.11% | |||
| EPS Diluted | -15.53% | -0.09% | |||
| Normalized Diluted EPS | 12.81% | -9.82% | |||
| Average Basic Shares Outstanding | -5.88% | -1.80% | |||
| Average Diluted Shares Outstanding | -6.58% | -2.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||